can tirzepatide cause bone loss The Hidden Risk of GLP-1 Medications: Osteopenia and How to Protect Your Health GLP-1s and bone loss! |
Description
Patients and Methods Six patients with DKD received 3 mg/day semaglutide orally
Clinical trials have demonstrated that patients using semaglutide can achieve substantial weight loss compared to those on a placebo, making it a valuable tool in the fight against obesity
One specific concern is whether semaglutide can cause or worsen heart palpitations
Neuroprotection for age-related macular degeneration
There are also concerns regarding potential drug-interactions and a reduction in long-term efficacy due to tachyphylaxis [73]
